Orthoflaviviruses, including Dengue, Zika, yellow fever, and West Nile viruses, are transmitted primarily by mosquitoes and ticks, causing significant health issues worldwide. Addressing the global burden of these viruses highlights the critical need for advanced prevention, treatment, and control strategies. Currently open for submissions - Submit Here
Guest Edited by:
Professor Olli Vapalahti, PhD, Department Virology, Helsinki University Hospital, University of Helsinki, Finland
Professor Denis Kainov, PhD, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norway
For this cross-journal article collection, we welcome submissions from researchers, scientists, clinicians, and academics who are engaged in the scientific study of HIV/AIDS. Currently open for submissions - Submit Here
This thematic series emphasizes advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of different emerging and re-emerging coronaviruses. Currently open for submissions - Submit Here
Edited by Susanna K. P. Lau, Hayes Luk, Siddharth Sridhar, and Linfa Wang
The 1st International Symposium on Advances in Phage Therapeutics is set to take place between the 16th and 17th of June 2025 in Braga (Portugal).
Virology Journal is sponsoring the first-place prize for best presentation.
More information on the symposium can be found here.
Virology Journal is proud to announce our collaboration with the Global Virus Network (GVN), a premier international coalition of medical virology centres, to further our shared mission of advancing the global understanding of viruses and viral diseases.
Through this partnership, Virology Journal aims to amplify the impact of cutting-edge research by providing a platform for the GVN by publishing a series of commentaries on the theme of pandemic prevention. We look forward to the enriched content and insights this collaboration will bring to our readers and the broader scientific community.
The commentaries can be found here.
Virology Journal would like to thank all of our peer reviewers for their dedication and expertise. Their invaluable contributions have been instrumental in maintaining the high standards of the journal. We extend our thanks to each reviewer for their time, effort, and commitment to advancing scholarly research.
We are particularly pleased to recognise the most frequent reviewers of 2024, whose reliable work has significantly enhanced the quality of our publications:
Virology Journal is looking to recruit additional reviewers to our Trusted Reviewer Board. The board is open to early-career Virology researchers who would like to gain peer-review experience. Reviewers work closely with the editorial board and will be asked to review one manuscript per month.
Apply here.
Are you, or is someone you know, making a contribution to the UN's SDG3 by working to "ensure healthy lives and promote well-being for all at all ages"? Read our blog post to learn how to raise awareness for your work through our blog series. Applications can be made via our Google Form.
Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
Your browser needs to have JavaScript enabled to view this timeline
Discover all the article collections published in Virology Journal. Find out more.
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
Clinical Virology: Fred Kibenge, University of Prince Edward Island, Canada
Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Wan-Long Chuang, Kaohsiung Medical University, Taiwan
Herpes viruses: Tony Cunningham, The Westmead Institute for Medical Research, Australia
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: John Barr, University of Leeds, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Supriya Chakraborty, Jawaharlal Nehru University, India
Positive-strand RNA viruses: Jaquelline Germano de Oliveira, Fundação Oswaldo Cruz - Fiocruz, Brazil
Public health: Kin On Kwok, The Chinese University of Hong Kong
Retroviruses: Aguinaldo Pinto, Universidade Federal de Santa Catarina, Brazil
Veterinary DNA viruses: Walid Azab, Freie Universität Berlin, Germany
Veterinary RNA viruses: James Weger-Lucarelli, Virginia Tech, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal
Virology Journal, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
Alan McLachlan, Co-Editor-in-Chief
Alan McLachlan is a molecular geneticist and hepadnavirologist. He currently serves as a Professor in the Department of Microbiology and Immunology, University of Illinois Chicago, USA. His interests are focused on hepatitis viruses, primarily on hepatitis B virus (HBV) and its relationships to liver physiology. His research is currently directed toward understanding the relationships between HBV transcription and viral biosynthesis using both cell culture and animal models. His long-term goals include the identification of cellular gene products as targets for the development of small molecular weight antiviral compounds which, in combination with current nuceot(s)ide analog therapeutics, will resolve chronic HBV infections.
Leo Poon, Co-Editor-in-Chief
Leo Poon is a molecular virologist. He currently serves as a Professor in the School of Public Health, The University of Hong Kong and as a co-director of HKU-Pasteur Research Pole. He has strong interests in emerging viruses, including coronavirus and influenza virus. He researches on different aspects of these viruses, ranging from basic virology to clinical diagnosis. His ultimate goal is to use scientific findings to inform public health policy. Over the years, he has published about 290 peer-reviewed articles. Thus far, his work has been cited over 41,000 times and he has an H-index of 95 (Web of Science).
Citation Impact 2023
Journal Impact Factor: 4.0
5-year Journal Impact Factor: 3.8
Source Normalized Impact per Paper (SNIP): 0.971
SCImago Journal Rank (SJR): 1.016
Speed 2024
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 94
Usage 2024
Downloads: 2,767,001
Altmetric mentions: 7,066
Virology Journal